The Endocrine Effects of Nonhormonal Antineoplastic Therapy

I. Introduction II. Disorders of Glucose Metabolism A. Diabetes mellitus B. Glycosuria and ketonuria III. Disorders of Free Water Clearance A. Syndrome of inappropriate ADH (SIADH) B. Nephrogenic diabetes insipidus IV. Disorders of Mineral Metabolism A. Hypocalcemia B. Hypercalcemia C. Hypomagnesemia V. Metabolic Bone Diseases A. Osteoporosis B. Rickets or osteomalacia VI. Thyroid Disorders A. Serum thyroid hormone-binding protein abnormalities B. Hypothyroidism C. Thyrotoxicosis D. Thyroid neoplasm VII. Disorders of Lipid Metabolism A. Hypertriglyceridemia B. Hypercholesterolemia VIII. Adrenal Dysfunction A. Primary adrenal insufficiency B. Secondary adrenal insufficiency IX. Disorders of GH Secretion and Growth A. GH deficiency B. Growth retardation X. Reproductive Dysfunction A. Reproductive dysfunction due to hypothalamic-pituitary damage B. Gonadal toxicity XI. Prevention and Surveillance of Endocrine Side Effects A. Pediatric screening B. Adult screening.